Paperback. Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Seller Inventory # 9786630162813

Contact seller

Report this item

Bibliographic Details

Title: MicroRNA Diagnostics in Kidney Disease (Paperback)
Publisher: LAP Lambert Academic Publishing
Publication Date: 2026
Language: English
ISBN 10: 6630162811
ISBN 13: 9786630162813
Binding: Paperback
Condition: new

About this title

Synopsis

Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment.

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Seller's business information

APOLLO ONLINE CORP.
605 Geddes Street, Wilmington, DE, 19805, U.S.A.

Sale & Shipping Terms

Terms of Sale

We guarantee the condition of every book as it�s described on the Abebooks web sites. If you�ve changed
your mind about a book that you�ve ordered, please use the Ask bookseller a question link to contact us
and we�ll respond within 2 business days.
Books ship from California and Michigan.

Shipping Terms

Orders usually ship within 2 business days. All books within the US ship free of charge. Delivery is 4-14 business days anywhere in the United States.

Books ship from California and Michigan.

If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.

Shipping rates within U.S.A.

Shipping rates within U.S.A.
Order quantity	6 to 16 business days	6 to 14 business days
First item	US$ 0.00	US$ 0.00

Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.